Viatris VTRS
NASDAQ VTRS
$16.50 -0.11 (-0.66%)
As of: Sep 9, 2026 · 3:59 PM EDT

Viatris (VTRS) Receivables (2019 - 2026)

Viatris (VTRS) posted Receivables of $3.7 billion for Q2 2026, up 2.69% on a QoQ basis from $3.6 billion in Q1 2026, and down 1.36% year-over-year from $3.7 billion in Q2 2025.

Analysis

Viatris (VTRS) Receivables (2019 - 2026) Analysis & Trends

Viatris has reported Receivables for 8 years, with the latest figure at $3.7 billion in Q2 2026.

  • On a quarterly basis, Receivables fell 1.36% year-over-year to $3.7 billion in Q2 2026; TTM through Jun 2026 was $3.7 billion, a 1.36% decrease from a year earlier, with the FY2025 full-year figure at $3.5 billion, down 7.49% from the prior year.
  • Receivables was $3.7 billion for Q2 2026 at Viatris, up from $3.6 billion in the prior quarter.
  • The five-year high for Receivables was $4.6 billion in Q1 2022, with the low at $3.5 billion in Q4 2025.
  • Average Receivables over 5 years is $4.1 billion, with a median of $4.0 billion recorded in 2023.
  • The sharpest annual moves came in 2022 and 2024: Receivables fell 20.86% in 2022, then increased 12.61% in 2024.
  • Over 5 years, Receivables stood at $4.4 billion in 2022, then advanced by 4.37% to $4.6 billion in 2023, then fell by 17.69% to $3.8 billion in 2024, then fell by 7.49% to $3.5 billion in 2025, then climbed by 5.35% to $3.7 billion in 2026.
  • The last three Receivables figures came in at $3.7 billion (Q2 2026), $3.6 billion (Q1 2026), and $3.5 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn 3.49 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn 3.67 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn 1.06 Bn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn 1.61 Bn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 2.26 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn 211.59 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 274.47 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn 145.76 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn 23.27 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.67 Bn
Mar 31, 2026 3.58 Bn
Dec 31, 2025 3.49 Bn
Sep 30, 2025 3.83 Bn
Jun 30, 2025 3.72 Bn
Mar 31, 2025 3.67 Bn
Dec 31, 2024 3.77 Bn
Sep 30, 2024 4.58 Bn
Jun 30, 2024 4.45 Bn
Mar 31, 2024 4.47 Bn
Dec 31, 2023 4.58 Bn
Sep 30, 2023 4.25 Bn
Jun 30, 2023 4.09 Bn
Mar 31, 2023 3.97 Bn
Dec 31, 2022 4.39 Bn
Sep 30, 2022 3.84 Bn
Jun 30, 2022 4.29 Bn
Mar 31, 2022 4.63 Bn
Dec 31, 2021 4.76 Bn
Sep 30, 2021 4.85 Bn